Shufeng Li

Cutaneous Lymphoma International Consortium Study of Outcome in Advanced Stages of Mycosis Fungoides and Sézary Syndrome: Effect of Specific Prognostic Markers on Survival and Development of a Prognostic Model

Julia Scarisbrick, H. Miles Prince, Maarten H. Vermeer et al. · Journal of Clinical Oncology · 2015 · 421 citations · Full text

Medicine, Dermatology, Oncology +17

Most Patients With Cancer‐Associated Dermatomyositis Have Antibodies to Nuclear Matrix Protein NXP‐2 or Transcription Intermediary Factor 1γ

David Fiorentino, Lisa Christopher‐Stine, Lisa C. Zaba et al. · Arthritis & Rheumatism · 2013 · 401 citations · Full text

Life Sciences, Dermatology, Immunology +17

Phase II Investigator-Initiated Study of Brentuximab Vedotin in Mycosis Fungoides and Sézary Syndrome With Variable CD30 Expression Level: A Multi-Institution Collaborative Project

Youn H. Kim, Mahkam Tavallaee, Uma Sundram et al. · Journal of Clinical Oncology · 2015 · 281 citations · Full text

Medicine, Hematology, Oncology +17

Pembrolizumab in Relapsed and Refractory Mycosis Fungoides and Sézary Syndrome: A Multicenter Phase II Study

Michael S. Khodadoust, Alain H. Rook, Pierluigi Porcu et al. · Journal of Clinical Oncology · 2019 · 229 citations · Full text

Medicine, Oncology, Pharmacotherapy +13

Low-dose total skin electron beam therapy as an effective modality to reduce disease burden in patients with mycosis fungoides: Results of a pooled analysis from 3 phase-II clinical trials

Richard T. Hoppe, Cameron Harrison, Mahkam Tavallaee et al. · Journal of the American Academy of Dermatology · 2014 · 201 citations

Medicine, Clinical Sciences, Dermatology +5